Beyond BMI: why heart failure trials must quantify adiposity, not just obesity - PubMed
5 hours ago
- #Heart Failure
- #Adiposity
- #Clinical Trials
- The article emphasizes the need to measure adiposity, not just obesity, in heart failure trials.
- Current reliance on BMI (Body Mass Index) may not fully capture the complexities of adiposity in heart failure patients.
- The focus is particularly relevant for HFpEF (Heart Failure with Preserved Ejection Fraction) studies.
- The article suggests that more precise quantification of adiposity could lead to better clinical trial outcomes and patient care.